• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.淋病奈瑟菌分离株中 penA 突变与 mtrR、porB 和 ponA 突变共同导致对头孢克肟或头孢曲松的低敏感性。
J Antimicrob Chemother. 2010 Apr;65(4):669-75. doi: 10.1093/jac/dkp505. Epub 2010 Jan 21.
2
Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.独特的联合 penA/mtrR/porB 突变和 NG-MAST 菌株类型与“敏感”淋病奈瑟菌人群中头孢曲松和头孢克肟 MIC 增加相关。
J Antimicrob Chemother. 2014 Jun;69(6):1510-6. doi: 10.1093/jac/dkt543. Epub 2014 Feb 13.
3
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.对头孢克肟和头孢曲松敏感性降低的淋病奈瑟菌分离株:与penA、mtrR、porB1b和ponA基因多态性的关联
Antimicrob Agents Chemother. 2007 Jun;51(6):2117-22. doi: 10.1128/AAC.01604-06. Epub 2007 Apr 9.
4
Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.2009年至2013年阿根廷对超广谱头孢菌素敏感性降低的淋病奈瑟菌分离株的出现与传播
Sex Transm Dis. 2017 Jun;44(6):351-355. doi: 10.1097/OLQ.0000000000000603.
5
Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.2006 年至 2010 年意大利淋病奈瑟菌对头孢克肟和头孢曲松的敏感性。
Clin Microbiol Infect. 2012 Jun;18(6):558-64. doi: 10.1111/j.1469-0691.2011.03619.x. Epub 2011 Oct 3.
6
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.南非首例和第二例对头孢克肟治疗失败的耐头孢菌素淋病奈瑟菌感染的表型和遗传特征及其与头孢克肟治疗失败的关系。
J Antimicrob Chemother. 2013 Jun;68(6):1267-70. doi: 10.1093/jac/dkt034. Epub 2013 Feb 14.
7
Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.加拿大对头孢曲松和头孢克肟敏感性降低的淋病奈瑟菌分离株的出现和特征:2001-2010 年。
Sex Transm Dis. 2012 Apr;39(4):316-23. doi: 10.1097/OLQ.0b013e3182401b69.
8
Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.巴塞罗那淋病奈瑟菌的抗菌药物敏感性:penA、ponA、mtrR和porB基因突变以及与头孢菌素敏感性降低相关的NG-MAST序列类型
Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1549-56. doi: 10.1007/s10096-016-2696-7. Epub 2016 Jun 2.
9
Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.1996-2016 年日本福冈淋病奈瑟菌分离株的抗菌药物耐药性及分子特征
J Glob Antimicrob Resist. 2019 Jun;17:3-7. doi: 10.1016/j.jgar.2018.11.011. Epub 2018 Nov 15.
10
Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.西班牙加泰罗尼亚地区分离的两株高水平头孢曲松耐药淋病奈瑟菌的分子特征。
J Antimicrob Chemother. 2012 Aug;67(8):1858-60. doi: 10.1093/jac/dks162. Epub 2012 May 7.

引用本文的文献

1
Assessment of Antibiotic Resistance and Efflux Pump Gene Expression in Neisseria Gonorrhoeae Isolates from South Africa by Quantitative Real-Time PCR and Regression Analysis.通过定量实时聚合酶链反应和回归分析评估南非淋病奈瑟菌分离株中的抗生素耐药性和外排泵基因表达
Int J Microbiol. 2022 Oct 21;2022:7318325. doi: 10.1155/2022/7318325. eCollection 2022.
2
Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of .多药耐药变体的耐药机制和流行病学。
Int J Mol Sci. 2022 Sep 10;23(18):10499. doi: 10.3390/ijms231810499.
3
Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic Targeting Strains Potentially Eradicable by Cefixime.环介导等温扩增检测淋病奈瑟菌非镶嵌靶向菌株对头孢克肟的潜在可消除性。
Microbiol Spectr. 2022 Oct 26;10(5):e0233522. doi: 10.1128/spectrum.02335-22. Epub 2022 Aug 24.
4
Antimicrobial Resistance Profiling and Phylogenetic Analysis of Clinical Isolates From Kenya in a Resource-Limited Setting.资源有限环境下肯尼亚临床分离株的抗菌药物耐药性分析及系统发育分析
Front Microbiol. 2021 Jul 27;12:647565. doi: 10.3389/fmicb.2021.647565. eCollection 2021.
5
Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.革兰氏阴性菌中三部分外排和 1 型分泌系统的结构、组装和功能。
Chem Rev. 2021 May 12;121(9):5479-5596. doi: 10.1021/acs.chemrev.1c00055. Epub 2021 Apr 28.
6
Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.通过基因组群体分析揭示,2014年至2019年间在荷兰阿姆斯特丹出现了一株对头孢菌素敏感性降低的淋病奈瑟菌克隆株。
J Antimicrob Chemother. 2021 Jun 18;76(7):1759-1768. doi: 10.1093/jac/dkab082.
7
Shanghai Isolates Exhibit Resistance to Extended-Spectrum Cephalosporins and Clonal Distribution.上海分离株对超广谱头孢菌素呈现耐药性及克隆分布情况。
Front Microbiol. 2020 Oct 6;11:580399. doi: 10.3389/fmicb.2020.580399. eCollection 2020.
8
Surfactant-enhanced DNA accessibility to nuclease accelerates phenotypic β-lactam antibiotic susceptibility testing of Neisseria gonorrhoeae.表面活性剂增强 DNA 对核酸酶的可及性,加速淋病奈瑟菌表型β-内酰胺类抗生素药敏试验。
PLoS Biol. 2020 Mar 19;18(3):e3000651. doi: 10.1371/journal.pbio.3000651. eCollection 2020 Mar.
9
Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.使用分子抗菌药物耐药决定因子预测淋病奈瑟菌抗菌药物 MIC 的方程。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.02005-19.
10
Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015.加纳 2012-2015 年淋病奈瑟菌的抗菌药物耐药性(AMR)及分子特征。
PLoS One. 2019 Oct 10;14(10):e0223598. doi: 10.1371/journal.pone.0223598. eCollection 2019.

本文引用的文献

1
Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.淋病奈瑟菌中对头孢曲松和头孢克肟的染色体介导的中度耐药性遗传学
Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51. doi: 10.1128/AAC.00304-09. Epub 2009 Jun 15.
2
Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis.淋病奈瑟菌克隆群的分子流行病学鉴定,这些克隆群具有与感染人类免疫缺陷病毒和梅毒的特定高危人群相关的不同药敏谱。
J Clin Microbiol. 2008 Dec;46(12):3931-4. doi: 10.1128/JCM.00577-08. Epub 2008 Oct 8.
3
Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.淋病奈瑟菌感染的头孢布烯耐药性与治疗失败
Antimicrob Agents Chemother. 2008 Oct;52(10):3564-7. doi: 10.1128/AAC.00198-08. Epub 2008 Jul 28.
4
Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone.对头孢克肟和头孢曲松敏感性降低的淋病奈瑟菌临床分离株中青霉素结合蛋白2氨基酸序列的分析。
J Infect Chemother. 2008 Jun;14(3):195-203. doi: 10.1007/s10156-008-0610-7. Epub 2008 Jun 24.
5
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.临床淋病奈瑟菌菌株耐药性的基因标志物与药敏谱之间的关系。
Antimicrob Agents Chemother. 2008 Jun;52(6):2175-82. doi: 10.1128/AAC.01420-07. Epub 2008 Mar 31.
6
Clusters of circulating Neisseria gonorrhoeae strains and association with antimicrobial resistance in Shanghai.上海市淋病奈瑟菌循环菌株簇及其与抗菌药物耐药性的关联
J Antimicrob Chemother. 2008 Mar;61(3):478-87. doi: 10.1093/jac/dkm544. Epub 2008 Jan 27.
7
Applications of molecular testing in clinical laboratories for the diagnosis and control of gonorrhea.分子检测在临床实验室中用于淋病诊断和控制的应用。
Future Microbiol. 2006 Oct;1(3):317-24. doi: 10.2217/17460913.1.3.317.
8
Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone.来自澳大利亚悉尼的淋病奈瑟菌菌株中,对头孢曲松敏感性降低的penA改变和亚型的多样性。
Antimicrob Agents Chemother. 2007 Sep;51(9):3111-6. doi: 10.1128/AAC.00306-07. Epub 2007 Jun 25.
9
Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.美国疾病控制与预防中心《2006年性传播疾病治疗指南》更新内容:不再推荐使用氟喹诺酮类药物治疗淋球菌感染。
MMWR Morb Mortal Wkly Rep. 2007 Apr 13;56(14):332-6.
10
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.对头孢克肟和头孢曲松敏感性降低的淋病奈瑟菌分离株:与penA、mtrR、porB1b和ponA基因多态性的关联
Antimicrob Agents Chemother. 2007 Jun;51(6):2117-22. doi: 10.1128/AAC.01604-06. Epub 2007 Apr 9.

淋病奈瑟菌分离株中 penA 突变与 mtrR、porB 和 ponA 突变共同导致对头孢克肟或头孢曲松的低敏感性。

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.

机构信息

Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Antimicrob Chemother. 2010 Apr;65(4):669-75. doi: 10.1093/jac/dkp505. Epub 2010 Jan 21.

DOI:10.1093/jac/dkp505
PMID:20093260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2837549/
Abstract

OBJECTIVES

To examine mutations within the penA, mtrR, porB, ponA and pilQ genes of Neisseria gonorrhoeae to determine their contribution to cephalosporin resistance.

METHODS

A total of 46 N. gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone (MICs > or = 0.12 mg/L) and two susceptible isolates were selected. The full sequence of penA and partial sequences previously reported as hot mutation sites of the other genes were analysed. Genotyping by N. gonorrhoeae multiantigen sequence typing (NG-MAST) was also performed.

RESULTS

A mosaic penicillin-binding protein 2 (PBP 2) was found in a single isolate that exhibited the highest cefixime MIC (0.5 mg/L). The majority of the isolates with reduced susceptibility to cephalosporins contained non-mosaic PBP 2 sequences, of which PBP 2 pattern XIII was most common (28/46). All isolates with reduced susceptibility to cephalosporins also had mtrR and porB mutations. Two susceptible isolates had the PBP 2 pattern XIV and an incomplete MtrR protein, which was a new mutation. Isolates with identical PBP 2 patterns comprised multiple NG-MAST sequence types.

CONCLUSIONS

Reduced susceptibility of N. gonorrhoeae to ceftriaxone and cefixime was associated with diverse penA mutations, particularly PBP 2 pattern XIII containing an Ala-501-->Val substitution, together with mtrR and porB mutations. The existence of only one strain having the mosaic penA sequence indicated that ceftriaxone and cefixime resistance in Korea is mostly not associated with a mosaic penA sequence. Highly heterogeneous NG-MAST sequence types excluded the clonal expansion of a particular subtype.

摘要

目的

检测淋病奈瑟菌 penA、mtrR、porB、ponA 和 pilQ 基因内的突变,以确定其对头孢菌素耐药性的贡献。

方法

选择 46 株对头孢克肟或头孢曲松(MICs>或=0.12mg/L)敏感性降低和 2 株敏感的淋病奈瑟菌分离株。分析了 penA 全长序列和先前报道的其他基因热点突变位点的部分序列。还进行了淋病奈瑟菌多抗原序列分型(NG-MAST)基因分型。

结果

在一个头孢克肟 MIC 值最高(0.5mg/L)的分离株中发现了一种镶嵌青霉素结合蛋白 2(PBP 2)。大多数对头孢菌素敏感性降低的分离株含有非镶嵌 PBP 2 序列,其中 PBP 2 模式 XIII 最为常见(28/46)。对头孢菌素敏感性降低的所有分离株均存在 mtrR 和 porB 突变。2 株敏感分离株具有 PBP 2 模式 XIV 和不完整的 MtrR 蛋白,这是一种新的突变。具有相同 PBP 2 模式的分离株包含多种 NG-MAST 序列类型。

结论

淋病奈瑟菌对头孢曲松和头孢克肟的敏感性降低与多种 penA 突变相关,特别是含有 Ala-501-->Val 取代的 PBP 2 模式 XIII,以及 mtrR 和 porB 突变。仅有一株具有镶嵌 penA 序列的分离株表明,韩国头孢曲松和头孢克肟耐药性主要与镶嵌 penA 序列无关。高度异质性的 NG-MAST 序列类型排除了特定亚型的克隆扩张。